Caseware UK (AP4) 2024.0.164 2024.0.164 2024-07-312024-07-312023-08-01falseResearch and development on biotechnology35truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 12760444 2023-08-01 2024-07-31 12760444 2022-08-01 2023-07-31 12760444 2024-07-31 12760444 2023-07-31 12760444 c:Director5 2023-08-01 2024-07-31 12760444 d:ComputerEquipment 2023-08-01 2024-07-31 12760444 d:ComputerEquipment 2024-07-31 12760444 d:ComputerEquipment 2023-07-31 12760444 d:CurrentFinancialInstruments 2024-07-31 12760444 d:CurrentFinancialInstruments 2023-07-31 12760444 d:Non-currentFinancialInstruments 2024-07-31 12760444 d:Non-currentFinancialInstruments 2023-07-31 12760444 d:CurrentFinancialInstruments d:WithinOneYear 2024-07-31 12760444 d:CurrentFinancialInstruments d:WithinOneYear 2023-07-31 12760444 d:Non-currentFinancialInstruments d:AfterOneYear 2024-07-31 12760444 d:Non-currentFinancialInstruments d:AfterOneYear 2023-07-31 12760444 d:ShareCapital 2024-07-31 12760444 d:ShareCapital 2023-07-31 12760444 d:RetainedEarningsAccumulatedLosses 2024-07-31 12760444 d:RetainedEarningsAccumulatedLosses 2023-07-31 12760444 c:OrdinaryShareClass1 2023-08-01 2024-07-31 12760444 c:OrdinaryShareClass1 2024-07-31 12760444 c:OrdinaryShareClass1 2023-07-31 12760444 c:FRS102 2023-08-01 2024-07-31 12760444 c:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 12760444 c:FullAccounts 2023-08-01 2024-07-31 12760444 c:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 12760444 13 2023-08-01 2024-07-31 12760444 e:PoundSterling 2023-08-01 2024-07-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 12760444









ZYGOSITY LTD







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2024

 
ZYGOSITY LTD
REGISTERED NUMBER: 12760444

BALANCE SHEET
AS AT 31 JULY 2024

2024
2023
Note
£
£

  

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 5 
4,223
4,507

Cash at bank and in hand
  
98,187
133,479

  
102,410
137,986

Creditors: amounts falling due within one year
 6 
(13,780)
(6,537)

NET CURRENT ASSETS
  
 
 
88,630
 
 
131,449

TOTAL ASSETS LESS CURRENT LIABILITIES
  
88,630
131,449

Creditors: amounts falling due after more than one year
 7 
(1,000,000)
(1,000,000)

  

NET LIABILITIES
  
(911,370)
(868,551)


CAPITAL AND RESERVES
  

Called up share capital 
 8 
1
1

Profit and loss account
  
(911,371)
(868,552)

  
(911,370)
(868,551)


Page 1

 
ZYGOSITY LTD
REGISTERED NUMBER: 12760444
    
BALANCE SHEET (CONTINUED)
AS AT 31 JULY 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 





Dr I A Russell
Director

Date: 28 April 2025

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
ZYGOSITY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

1.


GENERAL INFORMATION

Zygosity Ltd is a private company limited by shares and was incorporated in England and Wales. The company's registered office address is CRUK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE.
The company's functional and presentational currency is GBP.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

GOING CONCERN

The financial statements have been prepared on the going concern basis which assumes that the Company will continue as a going concern for the foreseeable future. The trading losses reported to date are consistent with the Company's business plan as it progresses its research and development activities.
Given the investment received, together with the development progress achieved, the directors have a reasonable expectation that the Company will be able to meet its liabilities as they fall due for the foreseeable future and therefore continue to adopt the going concern basis.

 
2.3

RESEARCH AND DEVELOPMENT

Research and development expenditure is recognised in the Profit and Loss Account in the period in
which the expenditure is incurred.

 
2.4

PENSIONS

DEFINED CONTRIBUTION PENSION PLAN

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.5

TANGIBLE FIXED ASSETS

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
ZYGOSITY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

2.ACCOUNTING POLICIES (CONTINUED)


2.5
TANGIBLE FIXED ASSETS (CONTINUED)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Computer equipment
-
33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

DEBTORS

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

CREDITORS

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

SIMPLE AGREEMENTS FOR FUTURE EQUITY

Simple agreements for future equity are classified as long term liabilities until such point at which shares are purchased.


3.


EMPLOYEES




The average monthly number of employees, including directors, during the year was 3 (2023 - 5).

Page 4

 
ZYGOSITY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

4.


TANGIBLE FIXED ASSETS





Computer equipment

£



COST OR VALUATION


At 1 August 2023
5,454



At 31 July 2024

5,454



DEPRECIATION


At 1 August 2023
5,454



At 31 July 2024

5,454



NET BOOK VALUE



At 31 July 2024
-



At 31 July 2023
-

Page 5

 
ZYGOSITY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

5.


DEBTORS

2024
2023
£
£


Other debtors
2,681
2,924

Prepayments and accrued income
1,542
1,583

4,223
4,507



6.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024
2023
£
£

Trade creditors
11,280
1,855

Accruals and deferred income
2,500
4,682

13,780
6,537





7.


CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2024
2023
£
£

SAFE
1,000,000
1,000,000

1,000,000
1,000,000


SAFE (Simple Agreements for Future Equity) will be used to purchase shares at the earlier of a qualifying financing round and the longstop date.

Page 6

 
ZYGOSITY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

8.


SHARE CAPITAL

2024
2023
£
£
ALLOTTED, CALLED UP AND FULLY PAID



1,443,805 (2023 - 1,443,805) Ordinary shares of £0.000001 each
1
1


 
Page 7